22 -1 (21) 2018 — Muminov R.K., Karimov A.Kh., — ENDOCRINE DISORDERS IN DEPRESSIVE CONDITIONS

ENDOCRINE DISORDERS IN DEPRESSIVE CONDITIONS

Muminov R.K., Andijan State Medical Institute,

Karimov A.Kh., Andijan State Medical Institute,

Mirzaev A.A., Andijan State Medical Institute,

Saliev M.M., Andijan State Medical Institute,

Kozimzhonova I.F.Andijan State Medical Institute,

Resume,

Depression affects virtually all spheres – emotional, intellectual, strong-willed and necessarily motivational, which is manifested as subjective in the patient’s complaints, and objectively – in behavior change. A persistent decline in mood during depression is combined with a loss of interest in what was previously perceived by the patient as attractive, satisfying or joyful – various forms of leisure, communication, reading books, hobbies, professional activities, sex life, etc.

Keywords: depression, endocrine disorders, intellect, behavior, patient.

First page

81

Last page

82

For citation: Muminov R.K., Karimov A.Kh., Mirzaev A.A., Saliev M.M., Kozimzhonova I.F. Endocrine disorders in depressive conditions //New Day in Medicine 1(21)2018 81-82 https://cutt.ly/cneiTqE

List of References

  1. M.I. Balabolkin, E.M. Klebanova, V.M. Cremia. Differential diagnosis and treatment of endocrine diseases (guidance)./ M. “Medicine”, 2002.
  2. Korkina MV, Lakosina ND, Lichko AE, SergeevII ..Psychiatry.M . //MEDpress-inform. 2004. -576 pp.
  3. Grigsby AB, Anderson RJ, Freedland KE, et al. Prevalence of anxiety in adults with diabeets: a systematic review. //J Psychosom Res 2002; 53: 1053-60.
  4. Kessler RS, Wittchen HU. Patterns and correlates of generalized anxiety disorder in community samples. //J Clin Psychiatry 2002; 63 (suppl. 8): 4-10.
  5. EGStarostin. Generalized anxiety disorder and anxiety symptoms in general medical practice. //Rus. honey.journal. 2004; 12, 22 (222): 1277.
  6. Yu.A. Alexandrovsky. Mental disorders in general medical practice and their treatment. /M. GEOTAR-MED-2004. – 240 with.
  7. Wittchen H-U, Jakobi F. Size and burden of mental disorders in Europe – a critical review and appraisal of 27 studies. // EurNeuropsychopharmacol 2005; 15: 357-76
  8. G.G. Neznamov, S.A. Syunyakov, D.V. Chumakov, L.E. MametovaNew selective anxiolytic afobazole.//Journal of Neurology and Psychiatry. S. S. Korsakova. 2005; 105: 4: 35-40.
  9. A.Avedisova, V.O.Chakhava, Yu.E.Less, YVMalygin. New anxiolytic “Afobazol” in the treatment of generalized anxiety disorder (results of a comparative study with diazepam). //Consilium MedicumPsychiatryandpsychopharmacotherapy . – 2006 – Vol. 08 – No. 3.

file

download